Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 9856

1.

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.

van den Brand FF, van Nieuwkerk CMJ, Verwer BJ, de Boer YS, de Boer NKH, Mulder CJJ, Bloemena E, Bakker CM, Vrolijk JM, Drenth JPH, Tan ACITL, Ter Borg F, Ter Borg MJ, van den Hazel SJ, Inderson A, Tushuizen ME, Bouma G.

Aliment Pharmacol Ther. 2018 Aug 15. doi: 10.1111/apt.14939. [Epub ahead of print]

PMID:
30109891
2.

Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience.

Lemoinne S, Pares A, Reig A, Ben Belkacem K, Kemgang Fankem AD, Gaouar F, Poupon R, Housset C, Corpechot C, Chazouillères O.

Clin Res Hepatol Gastroenterol. 2018 Aug 9. pii: S2210-7401(18)30121-9. doi: 10.1016/j.clinre.2018.06.009. [Epub ahead of print]

PMID:
30100231
3.

Autoimmune diseases after hepatitis B immunization in adults: Literature review and meta-analysis, with reference to 'autoimmune/autoinflammatory syndrome induced by adjuvants' (ASIA).

Elwood JM, Ameratunga R.

Vaccine. 2018 Aug 9. pii: S0264-410X(18)31094-6. doi: 10.1016/j.vaccine.2018.07.074. [Epub ahead of print]

PMID:
30100071
4.

Reply to: "Mortality due to immunotherapy related hepatitis".

De Martin E, Michot JM, Papouin B, Champiat S, Lambotte O, Robert C, Marabelle A, Guettier C, Samuel D.

J Hepatol. 2018 Aug 7. pii: S0168-8278(18)32261-X. doi: 10.1016/j.jhep.2018.07.009. [Epub ahead of print] No abstract available.

PMID:
30097327
5.

Incidence and clinical features of autoimmune hepatitis in the province of santa fe (Argentina).

Costaguta AC, González A, Pochettino S, Trotta L, Vicentín R, Wagener M.

J Pediatr Gastroenterol Nutr. 2018 Aug 8. doi: 10.1097/MPG.0000000000002122. [Epub ahead of print]

PMID:
30095578
6.

Immune Alterations in Patients With Type 1 Autoimmune Hepatitis Persist Upon Standard Immunosuppressive Treatment.

Renand A, Habes S, Mosnier JF, Aublé H, Judor JP, Vince N, Hulin P, Nedellec S, Métairie S, Archambeaud I, Brouard S, Gournay J, Conchon S.

Hepatol Commun. 2018 Aug 6;2(8):968-981. doi: 10.1002/hep4.1202. eCollection 2018 Aug.

7.

A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis.

Yamazaki T, Umemura T, Joshita S, Yoshizawa K, Tanaka E, Ota M.

Sci Rep. 2018 Aug 9;8(1):11924. doi: 10.1038/s41598-018-30406-9.

8.

Rethinking de novo immune hepatitis, an old concept for liver allograft rejection: Relevance of glutathione S-transferase T1 mismatch.

Aguilera I, Aguado-Dominguez E, Sousa JM, Nuñez-Roldan A.

World J Gastroenterol. 2018 Aug 7;24(29):3239-3249. doi: 10.3748/wjg.v24.i29.3239. Review.

9.

Evans Syndrome.

Shaikh H, Mewawalla P.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Jul 26.

10.

Receptor-interacting protein kinase 3 mediates macrophage/monocyte activation in autoimmune hepatitis and regulates interleukin-6 production.

Zhang J, Guo L, Liu M, Jing Y, Zhou S, Li H, Li Y, Zhao J, Zhao X, Karunaratna N, Jiang K, Zhou L, Wang B.

United European Gastroenterol J. 2018 Jun;6(5):719-728. doi: 10.1177/2050640618756124. Epub 2018 Jan 25.

11.

[Spondyloenchondrodysplasia with immune dysregulation: a case report and literature review].

Zhong LQ, Wang L, Song HM, Wang W, Wei M, He YY.

Zhonghua Er Ke Za Zhi. 2018 Aug 2;56(8):611-616. doi: 10.3760/cma.j.issn.0578-1310.2018.08.011. Chinese.

PMID:
30078244
12.

MicroRNAs in alcoholic liver disease: Recent advances and future applications.

Xu T, Li L, Hu HQ, Meng XM, Huang C, Zhang L, Qin J, Li J.

J Cell Physiol. 2018 Aug 4. doi: 10.1002/jcp.26938. [Epub ahead of print] Review.

PMID:
30076710
13.

Vulvovaginal-gingival-pilar lichen planus in a patient with autoimmune hepatitis.

Żychowska M, Woźniak Z, Maj J.

Int J Dermatol. 2018 Aug 3. doi: 10.1111/ijd.14184. [Epub ahead of print] No abstract available.

PMID:
30073668
14.

Inflammasome Priming Mediated via Toll-Like Receptors 2 and 4, Induces Th1-Like Regulatory T Cells in De Novo Autoimmune Hepatitis.

Arterbery AS, Yao J, Ling A, Avitzur Y, Martinez M, Lobritto S, Deng Y, Geliang G, Mehta S, Wang G, Knight J, Ekong UD.

Front Immunol. 2018 Jul 19;9:1612. doi: 10.3389/fimmu.2018.01612. eCollection 2018.

15.

Cryoglobulinaemia.

Roccatello D, Saadoun D, Ramos-Casals M, Tzioufas AG, Fervenza FC, Cacoub P, Zignego AL, Ferri C.

Nat Rev Dis Primers. 2018 Aug 2;4(1):11. doi: 10.1038/s41572-018-0009-4. Review.

PMID:
30072738
16.

Early mortality after liver transplantation: Defining the course and the cause.

Baganate F, Beal EW, Tumin D, Azoulay D, Mumtaz K, Black SM, Washburn K, Pawlik TM.

Surgery. 2018 Jul 30. pii: S0039-6060(18)30225-3. doi: 10.1016/j.surg.2018.04.039. [Epub ahead of print]

PMID:
30072250
17.

Inflammatory myopathy and autoimmune hepatitis in a patient with a flare of systemic lupus erythematosus: An exceptional association.

Salman-Monte TC, Carrión-Barberà I, García CP, Beltrán JG, Monfort J.

Eur J Rheumatol. 2018 Jan 22:1-4. doi: 10.5152/eurjrheum.2018.17135. [Epub ahead of print]

PMID:
30071929
18.

A case of immune-mediated liver injury induced by Olaparib.

Tufoni M, Ricci CS, Zaccherini G.

Hepatology. 2018 Aug 2. doi: 10.1002/hep.30119. [Epub ahead of print]

PMID:
30070367
19.

Clinicopathological features of He Shou Wu-Induced Liver Injury: This Ancient Anti-Aging Therapy Is Not Liver-Friendly.

Wang Y, Wang L, Saxena R, Wee A, Yang R, Tian Q, Zhang J, Zhao X, Jia J.

Liver Int. 2018 Aug 1. doi: 10.1111/liv.13939. [Epub ahead of print]

PMID:
30066422
20.

Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress.

Zampino R, Marrone A, Rinaldi L, Guerrera B, Nevola R, Boemio A, Iuliano N, Giordano M, Passariello N, Sasso FC, Albano E, Adinolfi LE.

Infection. 2018 Jul 31. doi: 10.1007/s15010-018-1185-6. [Epub ahead of print]

PMID:
30066228

Supplemental Content

Loading ...
Support Center